CTNND1 and breast cancer: To determine whether p120-catenin phosphorylation is altered with E-cadherin activation in tumor cells with the ability to metastasize, we treated the murine 4T1 breast cancer cells with anti-mouse E-cadherin functional monoclonal antibodies (mAb) (described in Na et al. [28]).